Click Therapeutics™ Reports Preliminary Results of a 416-Participant Clinical Study Demonstrating Exceptional Engagement and Efficacy of Clickotine®, a Patent-Pending Digital Therapeutics™ Program for Smoking Cessation (press release):
“Click Therapeutics, Inc. (“Click”), a company developing a suite of personalized data-driven digital therapeutics for chronic health conditions, announces today preliminary results of its fully remote clinical trial of Clickotine, a digital program designed for smoking cessation. Read the rest of this entry »
FDA Has Cleared New Cognitive Screening Tests (Alzforum):
“The Food and Drug Administration recently cleared, meaning it deemed safe, two tests that may help doctors screen for cognitive decline. One is the so-called Cognision system from Neuronetrix, a company based in Read the rest of this entry »
Time for SharpBrains’ January e-newsletter, featuring a wealth of brain health insights, neuroscience research reports, a landmark action by the Federal Trade Commission…and some quick brain teasers. Enjoy!
Finally, when you have a few minutes you may want to try these quick brain teasers to test your cognitive skills…and your cognitive biases.
Have a great month of February!
First ADHD brain wave test approved by FDA (CBS News):
“Diagnosing someone with attention deficit hyperactivity disorder (ADHD) is often a tricky science because it relies heavily on psychiatric and behavioral examinations. For the first time, the Food and Drug Administration has approved a device that Read the rest of this entry »
Envisioning The Future With Inventor Cori Lathan (NPR): “Computers were created to be useful tools, but all too often it’s still a chore to get technology to do our bidding…For example, working as an engineer with astronauts at NASA, Lathan realized that the physical challenges of living in space in some ways mirror the challenges of living with a disability on Earth. Read the rest of this entry »